COVID-19: Atypical GI Presentations
There are increasing data to support that many patients with COVID-19 can develop a myriad of gastrointestinal symptoms, which include mild diarrhea, nausea, vomiting and abdominal pain.
GI Illness
GI Illness
Feature Article
Latest News
GII.4 Genotype Most Common in Sporadic Pediatric Acute Gastroenteritis
Children with GII.4 type norovirus had more severe symptoms and required more medical care.
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile in Cirrhosis
A team of investigators sought to investigate the rate of resolution of Clostridioides difficile infection as well as safety associated with fecal microbiota transplantation in patients with liver cirrhosis.
Salmonella Outbreak in 15 States Being Investigated by CDC
A Salmonella outbreak that has sickened 125 people in 15 states is being investigated by the U.S. Centers for Disease Control and Prevention.
Gastrointestinal Symptoms Associated With COVID-19 Infection
A team of investigators conducted a comprehensive search of several databases to identify the prevalence of gastrointestinal symptoms in patients with COVID-19 infection.
Guideline Issued on the Use of Probiotics for Managing GI Disorders
Probiotics should only be recommended for specific patient populations since there is not enough evidence to support their use in the majority of digestive conditions, according to new clinical guidelines released by the American Gastroenterological Association (AGA) and recently published in Gastroenterology.
Bezlotoxumab Effective for Reducing Clostridioides difficile Recurrence
A post hoc analysis was conducted to assess the efficacy of bezlotoxumab in a subgroup of participants from the MODIFY I and II trials.
CDC: U.S. Salmonella Cases Linked to Backyard Poultry Reach 465
The number of Salmonella infections linked with backyard poultry has reached 465 in 42 states, an increase of 368 since the last update on May 20.
Cyclospora Outbreak Linked to Bagged Salad Mixes
19 people have been hospitalized with no deaths reported.
Distinct Phenotype of Pancreatitis Observed in Patients with SARS-CoV-2 Infection
SARS-CoV-2-associated pancreatitis may represent a distinct phenotype of pancreatitis characterized by metabolic stress, abdominal pain, and specific patterns of inflammation.
Timing of Bacterial Infection Eradication Therapy Affects Neoplasm Risk in Early Gastric Cancer
Prescription of Helicobacter pylori eradication therapy within 1 year of gastric cancer treatment reduces the risk of later metachronous lesion development.
Detection of Hypervirulent Klebsiella pneumoniae Strains in New York City
A team of researchers conducted surveillance at a New York City hospital to assess the prevalence K pneumoniae.
Dysbiosis of the Gut Microbiome Caused by Cigarette Smoke Promotes Cancer
Depression alters the structure of the gut microbiome in patients with autoimmune hepatitis and could contribute to the progression of liver cirrhosis.
Fecal Microbiota Transplantation for Treatment of Recurrent Clostridiodes difficile Effective in UC
Researchers assessed the microbial profiles of patients with IBD with recurrent C. difficile infection.
Besifovir Dipivoxil Maleate Effective, Safe for Long-Term Treatment of Chronic Hepatitis B
Study data supports the long-term efficacy and safety of besifovir dipivoxil maleate (BSV) for the treatment of chronic hepatitis B (CHB).
New Guidance for Commencing IBD Treatment During the COVID-19 Pandemic
Patients with IBD should not alter their treatment during the COVID-19 pandemic; however, starting a new treatment regimen should be avoided.
Could the Gut Microbiome be a Potential Treatment Target for COVID-19?
A pilot study from Hong Kong has provided evidence of prolonged gut dysbiosis in patients hospitalized with COVID-19.
High-Risk Regions for Childhood Diarrheal Mortality
Childhood mortality due to diarrhea remains high in some regions due to a combination of child growth failure, poor water, sanitation, and hygiene, and low oral rehydration therapy coverage.
High H pylori Eradication Rate with Rifabutin-Based Therapy
A novel rifabutin-based therapy (RHB-105) may be a potential first-line defense against Helicobacter pylori (H. pylori) infection.
Revised Clostridioides difficile Practice Guidelines Had Significant Effect on Treatment Decisions
Publication of the revised clinical practice guidelines for Clostridioides difficile infection was followed by significant increases in use of oral vancomycin and fidaxomicin, and a significant decrease in use of oral metronidazole.
Good Prognosis for Patients with Inflammatory Bowel Disease and COVID-19
Patients with inflammatory bowel disease (IBD) who tested positive for SARS-CoV-2 had a good overall prognosis, despite IBD maintenance treatment.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in GI Illness
